Flex Biomedical Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Flex Biomedical General Information

Description

Developer of novel treatments and diagnostics intended to cure orthopedic diseases. The company's diagnostics are based on synthetic polymer designed to treat osteoarthritis, an incurable joint disease that affects millions around the world, enabling patients to stay active and maintain the freedom of movement while minimizing pain.

Contact Information

Website
www.flexbio.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 555 D'Onofrio Drive
  • Suite 102
  • Madison, WI 53719
  • United States
+1 (608)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • 555 D'Onofrio Drive
  • Suite 102
  • Madison, WI 53719
  • United States
+1 (608)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Flex Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 01-Mar-2021 Completed Profitable
7. Later Stage VC 13-Sep-2013 Completed Profitable
6. Early Stage VC 13-Jun-2012 Completed Profitable
5. Early Stage VC 29-Aug-2011 Completed Profitable
4. Early Stage VC 27-Jan-2011 Completed Profitable
3. Early Stage VC 03-Nov-2010 Completed Profitable
2. Grant 02-Nov-2010 $419K $1.14M Completed Startup
1. Early Stage VC 12-Jun-2009 $1.14M $1.14M Completed Startup
To view Flex Biomedical’s complete valuation and funding history, request access »

Flex Biomedical Patents

Flex Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2012102861-A1 Polymer - active agent conjugates Inactive 24-Jan-2011
US-20130344023-A1 Polymer-active agent conjugates Inactive 24-Jan-2011
WO-2012097078-A2 Viscosupplementary materials Inactive 14-Jan-2011
WO-2012097078-A3 Viscosupplementary materials Inactive 14-Jan-2011 A61L27/16

Flex Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Flex Biomedical Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Arthritis and Musculoskeletal Diseases Not-For-Profit Venture Capital
To view Flex Biomedical’s complete investors history, request access »

Flex Biomedical FAQs

  • When was Flex Biomedical founded?

    Flex Biomedical was founded in 2007.

  • Where is Flex Biomedical headquartered?

    Flex Biomedical is headquartered in Madison, WI.

  • What is the size of Flex Biomedical?

    Flex Biomedical has 2 total employees.

  • What industry is Flex Biomedical in?

    Flex Biomedical’s primary industry is Pharmaceuticals.

  • Is Flex Biomedical a private or public company?

    Flex Biomedical is a Private company.

  • What is Flex Biomedical’s current revenue?

    The current revenue for Flex Biomedical is .

  • How much funding has Flex Biomedical raised over time?

    Flex Biomedical has raised $4.73M.

  • Who are Flex Biomedical’s investors?

    National Institutes of Arthritis and Musculoskeletal Diseases has invested in Flex Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process